| Title | Synthesis of new hypoxia markers EF1 and [F-18]-EF1 |
| Publication Type | Journal Article |
| Year of Publication | 1999 |
| Authors | Kachur, AV, Dolbier, WR, Evans, SM, Shiue, CY, Shiue, GG, Skov, KA, Baird, IR, James, BR, Li, AR, Roche, A, Koch, CJ |
| Journal | Applied Radiation and Isotopes |
| Volume | 51 |
| Pagination | 643-650 |
| Date Published | Dec |
| Type of Article | Article |
| ISBN Number | 0969-8043 |
| Keywords | ADDUCTS, CARCINOMA, CELLS, DEPENDENCE, F-18 FLUOROMISONIDAZOLE, IMAGING TUMOR HYPOXIA, INVIVO, ischemia, NONINVASIVE ASSESSMENT, REDUCTION |
| Abstract | We report on the preparation of a hypoxia marker 2-(2-nitroimidazol-1[H]-yl)-N-(3-fluoropropyl)acetamide (EF1) and its F-18 analog, 2-(2-nitroimidazol-1[H]-yl)-N-(3-[F-18]fluoropropyl)acetamide ([F-18]-EF1). Two methods for the preparation of 3-fluoropropylamine, the EF1 side chain, are described. [F-18]-EF1 was prepared with a radiochemical yield of 2% by nucleophilic substitution of bromine in 2-(2-nitroimidazol-1[H]-yl)-N-(3-bromopropyl) acetamide (EBrl) by carrier-added F-18 in DMSO at 120 degrees C. Our results demonstrate the preparation of clinically relevant amounts of [F-18]-EF1 for use as a non-invasive hypoxia marker with detection using positron emission tomography (PET). (C) 1999 Elsevier Science Ltd. All rights reserved. |
| URL | <Go to ISI>://000082954500006 |